Best Semaglutide Providers in 2026: Compared and Ranked

Summary: The best semaglutide provider in 2026 depends on whether you want brand-name Wegovy through the cheaper NovoCare direct route, full-service telehealth with insurance support, or a shrinking pool of compounded options after the FDA closed the shortage in 2025.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: there is no single best semaglutide provider, and anyone telling you otherwise is selling something. In 2026 the question splits cleanly into three lanes. If you want brand-name Wegovy at the cheapest possible self-pay price, NovoCare Pharmacy direct from Novo Nordisk wins on price. If you want full clinical support with insurance billing handled for you, Ro, Hims and Hers, LifeMD, WeightWatchers Clinic, and Mochi Health are the serious telehealth contenders. If you want compounded semaglutide for under $200, your options have shrunk dramatically since the FDA declared the shortage resolved in early 2025, and the legitimate paths that remain are narrower than the ads suggest ^[1].

This page lays out who prescribes what, what it costs, who handles insurance, who ships fastest, and who each provider is genuinely best for. No winner crowned. An evaluation framework you can run against your own situation.

What changed in 2026: the shortage is over

From mid-2022 through early 2025, semaglutide injection sat on the FDA Drug Shortage list. That status had a specific legal effect under Section 503A of the Federal Food, Drug, and Cosmetic Act: state-licensed compounding pharmacies were allowed to produce semaglutide for individual patients while the brand was unavailable. That window is what created the entire compounded telehealth boom. Hundreds of platforms sprang up offering compounded semaglutide for $150 to $300 per month while Wegovy and Ozempic cost $900 to $1,400 retail.

In February 2025, the FDA resolved the semaglutide injection shortage ^[1]. The agency then proposed adding semaglutide, tirzepatide, and liraglutide to the 503B bulks list with restrictions, which large-scale 503B outsourcing facilities had been using to produce compounded GLP-1 at scale. Several major compounding labs ceased semaglutide production in early 2026. A public comment period on the final 503B rules ran into mid-2026.

What this means for you as a patient in May 2026: compounded semaglutide is still legal when there is a documented individual medical need that the FDA-approved product cannot meet, for example a patient with an allergy to a brand-name excipient, or a specific dose not made by Novo Nordisk. It is no longer legal to mass-prescribe compounded semaglutide simply because it is cheaper than Wegovy. Some telehealth platforms still advertise compounded semaglutide; the legally compliant ones now route it through 503A pharmacies on a case-by-case clinical justification, not as a default product ^[2]. Many former compounded-semaglutide platforms quietly pivoted to compounded tirzepatide (which has its own evolving FDA status) or to brand-name Wegovy via the new direct-pay route Novo opened in 2025.

The provider landscape, by category

There are five categories worth knowing. Each has different tradeoffs.

1. Manufacturer direct: NovoCare Pharmacy and LillyDirect

In March 2025, Novo Nordisk launched NovoCare Pharmacy, which ships Wegovy directly to self-pay patients ^[3]. As of 2026 the published price is $499 per month for all Wegovy dose strengths, with a subscription option that brings it lower for longer commitments. Eli Lilly runs an equivalent program called LillyDirect for Zepbound and Mounjaro ^[4]. Zepbound vials (not pens) self-pay through LillyDirect at $349 for the 2.5 mg and 5 mg doses and $549 for higher doses, also subscription-discounted.

A second wrinkle landed in March 2026: Novo opened a Wegovy subscription program through Ro, WeightWatchers Clinic, LifeMD, Hims and Hers, and Sesame, with 12-month plans at $249 per month for both injections and pills. This is brand-name Wegovy, FDA-approved, shipped by Novo. The telehealth platform handles the clinical visit and prescription; Novo handles the medication. For self-pay patients this is the cheapest path to genuine Wegovy that exists.

Best for: Anyone who wants FDA-approved semaglutide at the lowest brand-name price and is paying out of pocket. Insurance copays through normal pharmacy benefit channels can still be lower (as little as $25 a month if your plan covers Wegovy), but if your plan excludes weight-loss drugs, NovoCare and the subscription telehealth route undercut every other legal path to brand-name Wegovy.

2. National telehealth platforms (brand-name semaglutide)

These are the platforms that handle the clinical visit, prescribe Wegovy or Ozempic, and either bill insurance for you or sell the manufacturer subscription. The big names in 2026:

• Ro Body: Compounded GLP-1 history, now also a Novo subscription partner. Ro Body program is $99 the first month and $145 to $149 a month after that, on top of medication cost. Available in 41 states; excluded states include Alabama, Alaska, Arkansas, California, Hawaii, Louisiana, Mississippi, Virginia, and DC. Strong insurance concierge service for prior authorizations.
• Hims and Hers: Entered the GLP-1 market aggressively in 2024 with compounded semaglutide; in 2026 the focus shifted to FDA-approved Wegovy through the Novo subscription. Hims and Hers carries both Wegovy injection at every dose strength and the oral Wegovy pill at 1.5, 4, 9, and 25 mg. Through August 31, 2026 the 1.5 mg and 4 mg pills are $149 per month as a promotional rate.
• WeightWatchers Clinic (formerly Sequence): Bundles GLP-1 prescriptions with the WeightWatchers behavioral program. Membership is around $99 a month plus medication. Strong on lifestyle integration, weaker on aggressive self-pay pricing than NovoCare direct.
• LifeMD: $249 to $499 per month covering medication and clinical visits, including both brand-name and (when justified) compounded options. Lower-touch than Ro on coaching.
• Sesame: Marketplace model. You pick your own physician from the directory, pay $195 plus for a 3-month weight-loss program, and your chosen provider writes the prescription. Brand-name only. Sesame Plus membership ($99 a year) layers on discounts.
• PlushCare: $15 per month membership plus per-visit copays; in-network with many insurers. Best when you have insurance that covers Wegovy because PlushCare can route the script to a retail pharmacy and your copay handles the medication.

3. Compounded-focused telehealth (now narrower)

These are the platforms whose entire business model was compounded semaglutide during the shortage. Some pivoted. Some still operate in the narrower 503A-justified niche or have moved emphasis to compounded tirzepatide.

• Henry Meds: $249 to $297 a month for compounded GLP-1. Still active in 2026 but with tighter clinical justification requirements.
• Mochi Health: $79 to $199 for compounded options, with full insurance concierge for brand-name. One of the more medically substantial of the compounding-era platforms.
• Future Health (Eden): Flat-rate pricing across dose escalations starting around $129 a month. Same-price-at-every-dose model.
• Push Health: Marketplace where individual prescribers list services; pricing varies widely. Lower clinical support than full-service platforms.
• Fridays Health: All-inclusive monthly fee with insurance support. Pricing around $200 to $300 a month depending on plan.
• Found: Coaching-led with $99 to $129 membership; medication cost is separate and not always covered by the membership. Strong on lifestyle support.
• Calibrate: Year-long behavioral program plus GLP-1 prescription. $1,600 to $1,800 upfront. Prescription routed to your retail pharmacy, so insurance coverage matters.
• Noom Med: GLP-1 layer on top of the Noom app. Plans from $69 a month plus medication. Best if you already use Noom.

Best for: Patients with a specific clinical need that the FDA-approved product cannot meet, or patients in a state where the compounded route remains available with documented justification. Increasingly NOT best for general self-pay weight loss in 2026; the $249 Novo subscription beat the math.

4. In-person obesity medicine clinics

Board-certified obesity medicine physicians at hospital systems and independent clinics still write the largest share of semaglutide prescriptions nationally. They have advantages telehealth cannot match: real labs drawn in office, in-person body composition or DEXA, longitudinal care if your weight management connects to type 2 diabetes, cardiovascular disease, or hormonal conditions, and direct coordination with your primary care.

The drawback is cost and access. Most obesity medicine clinics route prescriptions to your local Walgreens or CVS, which means if your insurance does not cover Wegovy you face the full $1,300 retail list price. Some clinics charge a monthly program fee on top.

Best for: Patients with complex medical histories, prediabetes or diabetes, prior bariatric surgery, polypharmacy, or anyone whose insurance covers Wegovy and just needs a prescriber.

5. Retail pharmacies (Walgreens, CVS, Rite Aid)

Not a "provider" exactly; the fulfillment endpoint. You still need a prescription. Pricing is whatever your insurance copay is, or list price if you self-pay. Some retail chains have partnered with telehealth services for in-app prescribing. Walgreens partnered with telehealth platforms in 2026 to offer the 4 mg Wegovy pill at $199 a month after August 31, 2026.

Provider comparison at a glance

How to choose: the framework that actually works

Forget rankings. Run your specific situation through these six questions.

Question 1: Does your insurance cover Wegovy?

Call the member services number on your card. Ask specifically: "Is Wegovy on my formulary for weight loss?" Most commercial plans require prior authorization that includes a BMI threshold (usually 30, or 27 with a comorbidity like hypertension or sleep apnea). Medicare Part D historically excluded GLP-1 for weight loss, though cardiovascular indications under Ozempic and Wegovy's 2024 label expansion changed the picture for some beneficiaries with established CV disease. Medicaid coverage varies dramatically by state.

If yes, your copay will likely beat any self-pay route. Use any provider who can write the script and bill your plan: your primary care, an obesity medicine specialist, PlushCare, Sesame, or any telehealth platform with insurance support.

If no, skip to question 2.

Question 2: Do you want brand-name or are you open to compounded?

Brand-name in 2026 is the simpler, safer, and increasingly cheaper choice for most self-pay patients. The Novo subscription at $249 per month through Ro, WeightWatchers, LifeMD, Hims and Hers, or Sesame is genuine FDA-approved Wegovy. It carries the full safety profile of the brand. It is delivered through a regulated supply chain. The math against compounded changed when the price gap closed.

Compounded only makes sense if you have a specific medical reason the brand cannot meet, you live in a state or insurance situation where the brand subscription is unavailable to you, or you need a non-standard dose. The blanket "compounded is cheaper" argument no longer holds when brand subscriptions exist at $249 a month.

Question 3: How much support do you actually want?

This is the variable that ruins more weight loss journeys than price does. Some people thrive on a stripped-down "send me the meds" platform. Most do not. The clinical trials showed semaglutide produces 15% to 20% body weight loss in supported populations. Real-world adherence in unsupported populations is dramatically worse, with discontinuation rates above 50% in the first year.

If you want hand-holding: WeightWatchers Clinic, Calibrate, Found, Noom Med, or an in-person obesity medicine clinic. You will pay more. The dropout protection is real.

If you want minimum-viable clinical support and self-direction: NovoCare direct, the Novo subscription via your preferred telehealth platform, or PlushCare with insurance.

Question 4: How fast do you need to start?

Telehealth platforms typically approve and ship within 1 to 3 business days after intake. NovoCare Pharmacy ships in roughly the same window. In-person clinic appointments can take weeks to schedule.

Question 5: What is your state situation?

Some telehealth platforms do not operate in every state. Ro Body excludes Alabama, Alaska, Arkansas, California, Hawaii, Louisiana, Mississippi, Virginia, and DC. Hims and Hers, Mochi, and others have similar but different exclusion lists. NovoCare ships to all 50 states. Always check your state on the provider's intake form before paying.

Question 6: Are you also a candidate for tirzepatide?

Semaglutide and tirzepatide are different drugs. In head-to-head data tirzepatide produces larger weight loss at maximum doses. If your goal is maximum weight loss and you have not committed to semaglutide specifically, the same providers above offer tirzepatide (Zepbound, Mounjaro, or compounded), and LillyDirect offers a Zepbound self-pay path equivalent to Novo's Wegovy subscription. We cover the tirzepatide provider landscape in a separate guide.

What to verify before you pay anyone

The FDA has issued warnings about counterfeit Ozempic and unregulated semaglutide sold as "research peptides" ^[5]. The 2024 study published in the Journal of Medical Internet Research tested products from six no-prescription-required websites; the three that delivered contained 28% to 38% more semaglutide than labeled, with poor purity and endotoxin contamination. The risk is not theoretical.

What about lab work?

Most legitimate semaglutide providers either order baseline labs or ask you to upload recent ones. The standard panel is a comprehensive metabolic panel, hemoglobin A1C, lipid profile, and sometimes thyroid function (TSH) and a pregnancy test for women of reproductive age. Some platforms skip labs entirely; that is a cost-saver, not a clinical upgrade. If you are starting a GLP-1 for the long haul, the baseline labs are worth doing. Repeat labs at six months catch the small percentage of patients who develop pancreatic, kidney, or gallbladder issues during titration.

What about the price for Ozempic specifically?

Ozempic is FDA-approved for type 2 diabetes, not weight loss. If you do not have type 2 diabetes, the path through insurance is harder; many plans deny Ozempic for off-label weight-loss use. Semaglutide for weight loss is Wegovy, even though the molecule is the same. Telehealth platforms typically steer self-pay weight-loss patients to Wegovy or compounded semaglutide, not Ozempic, because the indication match matters for the pharmacy's documentation and your future insurance appeals.

How to talk to your doctor about semaglutide

If you want to skip telehealth and use your primary care:

1. Bring your weight history, including past attempts at weight loss and what worked or did not.
2. Bring your most recent labs if you have them.
3. State your goal clearly: "I want to discuss whether semaglutide for weight management is appropriate for me."
4. Ask whether your insurance covers Wegovy and whether your doctor's office handles prior authorizations.
5. If your doctor declines and you disagree, ask for a referral to an obesity medicine specialist. Obesity medicine is a recognized board specialty; specialists are more comfortable prescribing GLP-1 than many generalists.

Common questions

What is the best semaglutide provider in 2026?

There is no single best. NovoCare Pharmacy is cheapest for brand-name self-pay; Ro, WeightWatchers Clinic, and Hims and Hers offer the Novo subscription with clinical support; Mochi and Found are strong if you want full programs. The best is the one matching your insurance, support, and state.

Where is the best place to get semaglutide cheaply without insurance?

The Novo Nordisk Wegovy subscription program, available through Ro, WeightWatchers, LifeMD, Hims and Hers, and Sesame, sells brand-name Wegovy at $249 per month on a 12-month plan. NovoCare Pharmacy direct is $499 per month.

Is compounded semaglutide still legal in 2026?

Yes, but with restrictions. The FDA resolved the semaglutide shortage in early 2025. State-licensed 503A pharmacies can still compound for individual patients when an FDA-approved product cannot meet the medical need. Blanket compounded prescribing for cost reasons alone is no longer permitted.

How much does Hims semaglutide cost?

Hims and Hers sells Wegovy through the Novo subscription program at $249 per month on a 12-month plan, $299 on 6-month, and $329 on 3-month. Promotional pill doses at 1.5 mg and 4 mg run $149 per month through August 31, 2026.

How much does Ro semaglutide cost?

Ro Body charges $99 for the first month and $145 to $149 monthly for the program, plus medication. Compounded semaglutide through Ro was historically $299 a month; brand-name Wegovy via the Novo subscription is $249 to $329 depending on plan length.

Is Mochi Health legitimate for semaglutide?

Yes. Mochi is a licensed telehealth platform with insurance concierge service, board-certified providers, and PCAB-accredited compounding partners. Compounded plans are $79 to $199 a month; brand-name with insurance varies.

Does WeightWatchers prescribe semaglutide?

WeightWatchers Clinic prescribes GLP-1 medications including Wegovy and Ozempic. Membership is roughly $99 a month plus medication. The Novo subscription runs $249 per month on a 12-month plan through the platform.

What is NovoCare Pharmacy?

NovoCare Pharmacy is Novo Nordisk's direct-to-patient self-pay program for Wegovy. Launched in March 2025, it ships brand-name Wegovy at $499 a month (lower on subscription) to self-pay patients without insurance involvement.

How do I get a semaglutide prescription online?

Pick a state-licensed telehealth platform, complete a health intake covering BMI, medical history, and current medications, attend or complete an asynchronous provider review, and receive a prescription shipped to you or sent to your pharmacy. Most platforms complete this in 1 to 3 days.

What labs do I need for semaglutide?

Standard baseline labs are a comprehensive metabolic panel, hemoglobin A1C, and a lipid panel. Some providers add thyroid function and a pregnancy test. Repeat labs are typical at 3 to 6 months, especially during dose titration.

Can I buy semaglutide without a prescription?

No. Semaglutide is a prescription medication in the United States. Any website selling injectable semaglutide without a prescription is operating outside US law, and FDA testing of such products has found counterfeit, overdosed, and contaminated samples.

Where can I buy Ozempic online?

Ozempic is a brand-name prescription medication. With a prescription, you can fill it at any retail pharmacy (Walgreens, CVS), or order through telehealth platforms that route prescriptions to a partner pharmacy. Ozempic is FDA-approved for type 2 diabetes; weight-loss-focused patients are usually prescribed Wegovy instead.

What this article does not cover

This page is about choosing a provider. It does not cover semaglutide dosing math, side effect management, what to expect month by month, or how to appeal an insurance denial for Wegovy. Those questions have dedicated guides on this site. Use the search or the sidebar to find them. The provider you pick will affect cost, support, and convenience; it will not change the underlying drug or how it works in your body. That part is the same whether your Wegovy ships from Novo, your local Walgreens, or a 503A compounder.